Skip to content

Clinical trials

Phase 1 Obesity trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Obesity Phase: Phase 1 Clear all

689 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20022
20034
20045
200512
200613
200714
200822
200925
201025
201120
201218
201323
201421
201513
201625
201715
201825
201919
202026
202121
202227
202337
202475
202587
2026110

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed441
Recruiting95
Not yet recruiting39
Active, not recruiting35
Unknown status30
Terminated26
Withdrawn19
Suspended3
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S85
Eli Lilly and Company38
Pfizer29
AstraZeneca22
Boehringer Ingelheim16
Amgen15
Mayo Clinic15
GlaxoSmithKline9
BrightGene Bio-Medical Technology Co., Ltd.8
Columbia University8

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Obesity689
Overweight267
Diabetes Mellitus, Type 275
Insulin Resistance35
Diabetes Mellitus34
Nutrition Disorders26
Weight Loss21
Metabolic Syndrome18
Non-alcoholic Fatty Liver Disease18
Hypertension17

Trials

Showing 51 to 75 of 689. Each trial links to its page on Pharma Observatory.

589 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.